Cramer's Morning Take: Eli Lilly 4/30/24 - Listen - Squawk on

Cramer's Morning Take: Eli Lilly 4/30/24

Listen now

Description

Jim and Jeff discuss Eli Lilly after the company beat on quarterly profit and hiked its full-year guidance on strong sales of Mounjaro and Zepbound. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake CNBC Investing Club Disclaimer

More Episodes

See all »

Cramer's Morning Take: Palo Alto 5/21/24

Jim Cramer breaks down earnings from this cybersecurity stock. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake CNBC Investing Club Disclaimer

Published 05/21/24

Nasdaq's Record Run, Fed's Waller on Rates, Dimon on Succession 05/21/24

Carl Quintanilla and Jim Cramer discussed tech sector momentum one day after a record closing high for the Nasdaq -- and ahead of Nvidia's earnings report due out after the bell Wednesday. The anchors also stayed on top of market reaction to comments from Fed Governor Christopher Waller on rates...

Published 05/21/24

Squawk on the Street

Published 05/21/24